Intermittent Fasting (IF)
An eating pattern based on cycles of eating and fasting, e.g., 16:8 — the evidence is solid for weight reduction, less conclusive for effects independent of caloric deficit.
Table of contents
TL;DR
An eating pattern based on cycles of eating and fasting, e.g., 16:8 — the evidence is solid for weight reduction, less conclusive for effects independent of caloric deficit.
- →Easier maintenance of a caloric deficit for some people thanks to a simpler meal structure
- →Improvement in select metabolic markers (insulin sensitivity) independent of weight loss in some studies
- →Possible support for autophagy processes with longer fasting windows
| Type of intervention | Eating pattern (timing of meals) |
|---|---|
| Evidence level | Moderate — strong mechanistic data, developing clinical data |
| Target group | People for whom a simpler meal structure makes a caloric deficit easier |
| Time to effects | Adaptation 1–2 weeks; weight effects usually measured after roughly 12 weeks |
| Preparation required | No equipment needed — requires time discipline |
| Status | A method / meal-timing pattern, not a diet that defines composition |
Understand
Overview
Intermittent fasting (IF) isn't a diet in the classic sense — it doesn't define what to eat, only the pattern of when meals are spread out over time. It has gained enormous popularity over the last decade as an alternative to classic calorie counting, partly thanks to its simplicity (fewer decisions to make during the day) and to autophagy research, which won the Nobel Prize in 2016.
The most popular protocols are 16:8 (16 hours of fasting, an 8-hour eating window — the most studied and easiest to implement), 5:2 (5 days of normal eating, 2 days with very low calorie intake of around 500–600 kcal), alternate-day fasting (ADF), and more restrictive variants such as 20:4 or OMAD (one meal a day).
In practice, the people who benefit most are those for whom IF makes it easier to maintain a caloric deficit — for example, people who tend to snack in the evenings or who don't handle counting calories at every meal well. Research shows, however, that the 16:8 protocol itself doesn't offer a weight advantage over three standard meals a day — it mainly works by making it easier to stick to the plan, not through a unique metabolic mechanism. It's a poor choice for people with a history of eating disorders (long windows without food can intensify restrictive thinking), pregnant or breastfeeding women, people with type 1 diabetes or on insulin therapy (the risk of hypoglycemia requires medical supervision), and those taking medications that need to be taken with food. Women in general should consider starting with gentler variants (e.g., 14:10 instead of 16:8) and monitoring their menstrual cycle, since data suggests greater sensitivity of the hormonal axis to long fasting periods.
Where it's found
Periodic abstention from food doesn't have a single geographic origin — fasting in one form or another has accompanied humanity since the dawn of history, for both practical reasons (irregular access to food among hunter-gatherers) and spiritual ones. Elements resembling modern IF can be found in religious traditions around the world — the Muslim Ramadan, the Jewish Yom Kippur, the Christian Lent, or Buddhist monastic practices of eating only until noon.
History of use
Scientific interest in fasting as a metabolic intervention rather than just a religious practice accelerated in the 20th century alongside research into caloric restriction in animals. The real breakthrough in popularization, however, came in the last decade — the spread of the 16:8 protocol by fitness coaches coincided with the 2016 Nobel Prize in Physiology or Medicine awarded to Yoshinori Ohsumi for discoveries on the mechanisms of autophagy, which sharply increased scientific and media interest in intermittent fasting as a biohacking tool, not just a weight-loss method.
Mechanism of action
An extended period without calories lowers insulin and liver glycogen levels, which after several hours favors switching metabolism toward fat burning (lipolysis and partial ketogenesis) and may enhance cellular autophagy — the mechanism that 'cleans up' damaged organelles and proteins. This phenomenon is sometimes called the 'metabolic switch' and, in animal studies, is associated with improvements in markers of oxidative stress and inflammation, although the scale of these effects in humans under typical protocols (e.g., 16:8) remains a subject of scientific debate.
At the cellular level, a key role is played by the reversal of the insulin-to-glucagon ratio — when blood glucose falls, the pancreas reduces secretion of insulin (an anabolic, energy-storing hormone) in favor of glucagon, which mobilizes glycogen and fat stores. The drop in insulin and activation of AMPK simultaneously inhibit the mTOR pathway — the main 'switch' controlling autophagy — which unlocks the formation of autophagosomes, the vesicles that remove damaged proteins and mitochondria. In humans this process takes longer than in mice, which is why the actual scale of autophagy under popular IF protocols remains difficult to precisely measure in people.
Depletion of liver glycogen
After roughly 8–12 hours without calories, liver glycogen stores become depleted, forcing the body to seek alternative energy sources.
Drop in insulin, rise in glucagon
Low glucose levels reduce insulin secretion and raise glucagon, switching metabolism into a stores-mobilization mode.
Lipolysis and partial ketogenesis
The body begins releasing and burning fatty acids from fat tissue, partially converting them into ketone bodies.
AMPK/mTOR-driven autophagy activation
The drop in insulin and cellular energy inhibits the mTOR pathway and activates AMPK, unlocking autophagy processes.
Spontaneous calorie reduction
A shorter eating window often leads to naturally eating fewer calories — this is the main mechanism behind the weight reduction observed in studies.
Evidence: moderate — based on 2 studies in this database.
Benefits
Forms & variants
Intermittent Fasting (IF) comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
16:8 (Leangains)
16 hours of fasting, an 8-hour eating window — the most popular and best-tolerated protocol, easy to fit into a daily rhythm (e.g., by skipping breakfast).
Best for: Beginners, people wanting a simple, balanced approach
5:2
5 days of normal eating, 2 non-consecutive days with calorie intake reduced to about 500–600 kcal.
Best for: People who prefer full days of normal eating over a daily window restriction
Alternate-day fasting (ADF)
Alternating days of normal eating and days of very low calorie intake or complete fasting — more restrictive, best studied in the context of weight reduction.
Best for: Advanced practitioners, under specialist supervision for longer-term use
OMAD (One Meal A Day)
One, usually substantial, meal a day within a 1–2 hour window — the most restrictive popular variant, hard to balance nutritionally.
Best for: Experienced IF practitioners, not as a first step
Practice
Frequently asked questions
Comparative studies indicate similar weight loss at an equal caloric deficit — the main advantage of IF for many people is easier adherence to the plan, not a unique metabolic mechanism.
Some data suggest women's hormonal axis is more sensitive to long fasting periods — gentler protocols (e.g., 14:10 instead of 16:8) and monitoring the menstrual cycle are recommended.
16:8 is usually recommended as a starting point — it's the best tolerated, easiest to maintain long-term, and has the most safety data in the general population.
Yes, black coffee and tea without additives (sugar, milk) don't break most definitions of a fast, since they don't provide a meaningful number of calories or trigger a significant insulin response.
Dosage & timing
Typical dose
Most studied protocol: 8-hour eating window / 16-hour fast, used 4–7 days a week
Form
An eating pattern, not a supplement
Metabolic effects largely stem from the caloric deficit achieved, not from fasting itself.
Best times to take it
- Flexible — the eating window is adjusted to daily rhythm and training schedule
Safety
Side effects & contraindications
Possible side effects
Irritability, reduced energy, and difficulty concentrating during the adaptation phase
Risk of overeating within the eating window
Contraindications
History of eating disorders
Pregnancy and breastfeeding
Type 1 diabetes or insulin therapy — only under medical supervision
Interactions
Medications that need to be taken with food — the schedule needs to be adjusted
Is it worth taking?
Who it's for
- Easier maintenance of a caloric deficit for some people thanks to a simpler meal structure
- Improvement in select metabolic markers (insulin sensitivity) independent of weight loss in some studies
- Possible support for autophagy processes with longer fasting windows
Not for
- History of eating disorders
- Pregnancy and breastfeeding
- Type 1 diabetes or insulin therapy — only under medical supervision
Evidence
Studies
In a randomized trial, time-restricted eating (the 16:8 protocol) led to similar weight loss as three standard meals a day.
Lowe DA et al., JAMA Internal Medicine, 2020
Effects of Intermittent Fasting on Health, Aging, and Disease
Moderate evidencede Cabo R, Mattson MP. · New England Journal of Medicine · 2019
A review of the metabolic mechanisms of intermittent fasting — strong preclinical data, moderate and still developing clinical data in humans.
View studyEffect of Time-Restricted Eating on Weight Loss
Moderate evidenceLowe DA, et al. · JAMA Internal Medicine · 2020
An RCT comparing time-restricted eating (16:8) to three standard meals a day — similar weight loss in both groups after 12 weeks.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
Michał NowakClinical Dietitian
Michał specializes in metabolic nutrition, intermittent fasting and sports supplementation.
46 publications on this site
Medical review
dr Piotr ZielińskiEndocrinologist
Piotr reviews content on hormones, metabolic health and supplement pharmacology.
47 publications on this site
Related entries
4.1NMN (Nicotinamide Mononucleotide)
An NAD+ precursor intensively studied in the context of cellular aging — human data are still early, despite huge market popularity.
4.3Berberine
A plant alkaloid sometimes called 'nature's metformin' — studies show a meaningful effect on blood glucose, though it doesn't replace pharmacological treatment.
4.9Mediterranean Diet
The best-studied eating pattern for cardiovascular health and longevity.
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.
